Egg allergy is one of the most common food allergies in children. Most egg-allergic children are able to tolerate egg baked in product (EBP) 
gg allergy is one of the most common food allergies in the pediatric population. 1 Recent literature has estimated 68% of egg-allergic children will tolerate plain egg by age 16 years, suggesting that the majority of children outgrow their egg allergy later than previously described. 2 Because egg is a common ingredient and avoidance can be burdensome, quality of life is negatively affected. 3 Approximately 80% of egg-allergic patients tolerate egg baked in product (EBP). 4 Leonard et al., and more recently, Peters et al., suggest egg-allergic patients who tolerate EBP with continued ingestion may tolerate plain egg sooner than those who strictly avoid all forms of egg. 5, 6 This phenomenon may represent the natural history of egg allergy according to Peters et al. 6 Thus, introduction of EBP to egg-allergic patients using oral food challenge (OFC) can expand diet and possibly accelerate tolerance to plain egg. We sought to retrospectively review the number of egg-allergic patients who passed EBP open OFC in our academic multipractitioner allergy clinic to help determine if any risk factors would predispose patients to OFC failure and if we can safely consider recommending OFC at home in appropriately chosen patients.
Children's Hospital of Wisconsin (CHW) Institutional Review Board approval was obtained. We reviewed charts of patients who underwent EBP OFC from January 2011 to July 2013. Each patient was diagnosed with clinical egg allergy based on clinical history and a positive skin-prick test to egg and/or serum-specific IgE to egg white during a clinic visit with an allergist at CHW. Patients were chosen for EBP OFC based on clinical judgment and family interest. No skin-prick testing size or level of serum-specific IgE to egg white was used as a cutoff for OFC. Nine patients who were sensitized to egg without symptomatic ingestion were excluded from further analyses. Table 1 summarizes clinical and laboratory characteristics of the remaining 34 patients challenged. Mann-Whitney nonparametric tests were used to compare groups with ordinal or continuous outcomes. Two-sided Fisher's exact tests were used to compare binary outcomes.
Thirty-one of 34 patients challenged used our standard EBP protocol consisting of a boxed cake mix with three eggs baked at 350°F for at least 30 minutes. The remaining three patients ingested baked cookies, donuts, or bread during OFC. Each patient was given variable amounts of EBP with no minimum amount of ingestion. Twenty-eight of 34 patients (82.4%) passed the EBP OFC. A positive or failed OFC was defined as when the patient refused to eat the EBP and/or had clinical symptoms with EBP ingestion requiring treatment. In one case, the caregiver was uncomfortable with continuation of the OFC after localized rash was observed and treated. Six patients failed: two did not complete the OFC secondary to being uncooperative with ingestion of EBP and four developed mild symptoms representing an IgE-mediated reaction needing treatment. The reactions of these four patients included one with localized rash only, two with gastrointestinal upset (one with nausea and abdominal discomfort and the other with nausea and subsequent emesis), and one with localized rash above the upper lip and wheeze cleared with cough. One of the four patients who failed EBP OFC did not ingest the standard baked boxed cake mix; the patient ingested baked cookies and had nausea and emesis during OFC. All four patients who had symptoms received an antihistamine and one received albuterol. No patients received epinephrine. On statistical analysis, no predictors were identified to be associated with an increased risk for failing EBP OFC (Table 1). However, a history of anaphylaxis on initial reaction did approach significance and may be a significant risk factor for failure if our sample size were larger.
EBP OFC is a valuable tool to assess tolerance and possibly to expand diet. Our study showed tolerance in Ͼ80% of patients, confirming previous studies. 4 -6 Given this high pass rate, EBP OFC should be considered for egg-allergic patients. Unfortunately, recent work, including our study, has not defined a significant specific factor to predict which egg-allergic patients will likely pass EBP OFC (Table 1) . Skin-prick test wheal size and serum-specific IgE are of particular interest to allergists but in our study skin-prick test wheal size did not differentiate between passing or failing the EBP OFC. There is a suggestion that IgE 
